Article
Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues.
Carcinogenesis - 1 Dec 2009
Zhao Ronghua, DeCoteau John F, Geyer C Ronald, Gao Mei, Cui Hengmi, Casson Alan G
Abstract excerpt
To evaluate loss of imprinting (LOI) and expression of the IGF2 gene in matched esophageal normal and adenocarcinoma tissues, we studied a prospective cohort of 77 patients who underwent esophageal resection between 1998 and 2003. IGF2 imprinting status was determined by reverse transcription-polymerase chain reaction (PCR) following ApaI digestion, and quantitative PCR was used to evaluate IGF2 expression, which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
